Cerus (CERS) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts CERS Hot Sheet
Price: $2.82 +4.06%
Financial Fact:
Amortization of intangible assets: 50K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Amortization of intangible assets: 50K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cerus (NASDAQ: CERS) reported Q2 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $37.7 million versus the consensus estimate of $31.48 million.
GUIDANCE:
Cerus sees FY2021 revenue of $118-122 million, versus the consensus of $134.8 million.
For earnings history and earnings-related data on Cerus (CERS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
